VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by Justberealon Apr 13, 2019 10:58am

102 Views

Post# 29622717

Sales in Chinese market is not gonna happen any time soon,

maybe in 2 years or 3. The Chinese partner Ma'anshan Yutian is such a small fish that they haven't got the device approved in the Medical Insurance Price Category, which is a must prior to being commercially available in China. If one knows how the system works out there, 2-3 years is typical. Can't help asking "are we still competitive at that time"? Snuff69, you heard what you liked to hear.

Bullboard Posts

Increasing summer travel could see these airline stocks soar